Clinical trial
A Single Center Study of the Safety and Efficacy of Multiple Intravitreal Injections of Ranibizumab in Subjects With CNV Secondary to Causes Other Than AMD.
NCT00395551 is registered in ClinicalTrials.gov with Ophthalmic Consultants of Boston as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single Center Study of the Safety and Efficacy of Multiple Intravitreal Injections of Ranibizumab in Subjects With CNV Secondary to Causes Other Than AMD.
- Lead sponsor
- Ophthalmic Consultants of Boston
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- December 31, 2005
- Completion date
- June 30, 2009
- Enrollment
- 30 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.